Here's How Qiagen Trounced Q1 Estimates
Qiagen (NYSE: QGEN) is definitely an outlier so far in 2020. While most stocks have struggled due to the COVID-19 pandemic, Qiagen's shares have marched upward throughout much of the year and are now up 24% year to date.
The molecular diagnostics company announced its first-quarter results after the market closed on Wednesday. Here are the highlights from Qiagen's Q1 update.
Image source: Qiagen.
Source Fool.com


